We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program

News   Aug 06, 2015

 
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program
 
 
Advertisement
 

RELATED ARTICLES

Repurposing Drugs To Manage COVID-19 Progression

News

Researchers have used a large-scale human genetics study to identify drug targets important for managing COVID-19 in its early stages.

READ MORE

mRNA Delivery System Produces Therapeutic Protein in Rat Brains

News

Researchers from Tokyo Medical and Dental University (TMDU) demonstrate an mRNA delivery system that effectively produces BDNF protein in rat brain to protect neurons from ischemia.

READ MORE

Inhibiting NLRP3 To Prevent Melanoma-Mediated Inflammation

News

Researchers have shown a reduction in tumor expansion and inflammation from the inhibition of NLRP3, an intracellular complex that participates in melanoma-mediated inflammation.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE